How Africure Pharmaceuticals Stands Out as a Leading Pharmaceutical Manufacturer in West Africa

In this section of the interview, Hari Anand explains the key competitive advantages that distinguish Africure Pharmaceuticals within Côte d’Ivoire’s pharmaceutical industry and the wider West African market. He highlights the company’s exceptional manufacturing capacity, noting that Africure Pharmaceuticals operates on a scale significantly larger than any other pharmaceutical plant in Côte d’Ivoire, with the ability to produce tablets, capsules, and syrups under one roof.

Hari Anand also emphasises the strength of the company’s product portfolio, which includes approximately 80 licensed pharmaceutical products registered in Côte d’Ivoire. He explains that obtaining regulatory approval is a rigorous process due to the country’s strict standards, which are aligned with World Health Organization requirements, making Africure Pharmaceuticals’ broad range of approved products a significant competitive asset.

Another important differentiator is the company’s focus on branded generic medicines. By manufacturing high-quality yet affordable pharmaceutical products locally, Africure Pharmaceuticals is able to make essential healthcare treatments accessible to a wider population while maintaining strong quality standards. Through its production capacity, diverse product range, regulatory compliance, and commitment to affordability, the company has established itself as a leading pharmaceutical manufacturer serving Côte d’Ivoire and the broader West African region.